Day 30 SUVmax predicts progression in patients with lymphoma achieving PR/SD after CAR T-cell therapy
Title:
Day 30 SUVmax predicts progression in patients with lymphoma achieving PR/SD after CAR T-cell therapy
Author:
Al Zaki, Ajlan Feng, Lei Watson, Grace Ahmed, Sairah A. Mistry, Haleigh Nastoupil, Loretta J. Hawkins, Misha Nair, Ranjit Iyer, Swaminathan P. Lee, Hun J. Steiner, Raphael E. Flowers, Christopher R. Shpall, Elizabeth J. Kebriaei, Partow Neelapu, Sattva S. Westin, Jason R. Strati, Paolo